News
MPP Association news
MPP Association Welcomes European Commission’s Proposal to Amend MDR and IVDR To Foster Innovation
Medtech & Pharma Platform Association (MPP) welcomes the European Commission’s publication of the long-awaited...
MPP Association letter to European Commission on MDR/IVDR targeted assessment
In the context of the anticipated targeted assessment of the Medical Devices and In Vitro Diagnostics Regulations (MDR...
MPP publishes position paper on impact of IVDR on use of in-house devices in clinical trials
The Medtech & Pharma Platform Association (MPP) is pleased to announce the publication of a paper entitled ‘Impact...
11th edition of the Medtech & Pharma Platform Association annual conference
21 October 2024 – Press release The 11th Medtech & Pharma Platform Association (MPP) Annual Conference (MPP 2024)...
The 11th edition of the Medtech & Pharma Platform Association annual conference kicks-off in Basel
3 September 2024 – Press release Today, the MPP Annual Conference, themed “Combined products of tomorrow – developing...
MDx CRO joins the MPP
We proudly welcome MDx CRO as the newest member of the Medtech & Pharma Platform (MPP) Association. We look...
Nomination of Designated Vice-President
At its last meeting in June 2024, the MPP Board of Directors put forward the proposal to nominate a Vice-President of...
MPP Association welcomes Gerresheimer as member
We are delighted to announce that Gerresheimer has become a member of the MPP Association, the leading European...
Outcome of the 2024 MPP General Assembly
The Medtech & Pharma Platform (MPP) Association held its annual General Assembly meeting on 29 April 2024. MPP...
MPP Association statement on the AI ACT
The MPP Association welcomes the adoption of the EU artificial intelligence (AI) Act by the European Parliament on 13...

